- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT06121661
APPRAISE 2.0: Live-Test des APPRAISE Trauma Decision Support Systems
This is a pilot evaluation of the APPRAISE trauma decision-support software system ("the System"). The specific objections are as follows:
- Evaluate the robustness of the System (i.e., whether the software performs in real-time in accordance with a priori technical specifications during real-time clinical use);
- Evaluate whether the real-time display of the System causes distraction or confusion to clinicians treating the trauma patient such that its risks exceed its benefits;
- Collect pilot data to allow for a statistical power analysis to design a future clinical trial evaluating efficacy.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Phase 1
Kontakte und Standorte
Studienkontakt
- Name: Yang Wang
- Telefonnummer: 6177262241
- E-Mail: YWANG132@mgh.harvard.edu
Studienorte
-
-
Massachusetts
-
Boston, Massachusetts, Vereinigte Staaten, 02460
- Rekrutierung
- Massachusetts General Hospital
-
Kontakt:
- Andrew T Reisner
- Telefonnummer: 6177262241
- E-Mail: areisner@mgh.harvard.edu
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Adult (≥18 yrs) Emergency Department (ED) patient
- Triaged to the "Acute" area of the ED. (The "Acute" area is the designated area for ED patients with potential or established critical illness. Triage to Acute is a routine ED operation that is performed based on departmental guidelines and the professional judgement of an experienced triage nurse).
- Clinical concern for acute injury (based on either an explicitly chief complaint of acute injury, or clinical team with documented concern for acute injury as a relevant part of patient presentation).
Exclusion Criteria:
- Prisoners
- Patients known to be pregnant, based on patient report, physical exam, or bedside ultrasound
- Patients wearing an "EFIC Opt-Out" bracelet
- Any concern about the suitability of the software system for a specific patient by any clinician involved in the patient's ED care, or by the patient themselves (or by any LAR [lawfully authorized representative] of the patient).
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Machbarkeit des Geräts
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: APPRAISE cases
Trauma patients for which APPRAISE system was used |
Real-time bedside decision-support system for trauma patient management |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Software session with error messages or critical software errors
Zeitfenster: From patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation).
|
Each time the software is used ("session"), a log file is generated. We will quantify how many sessions generate error messages or critical software errors. |
From patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation).
|
|
Clinician surveys that the software negatively affected patient care
Zeitfenster: From patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)
|
Each time the software is used, clinicians are surveyed whether the software negatively affected patient care, in their professional judgement |
From patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)
|
|
Clinician surveys that the software positively affected patient care
Zeitfenster: From patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)
|
Each time the software is used, clinicians are surveyed whether the software negatively affected patient care, in their professional judgement |
From patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)
|
|
Clinician surveys that ongoing use of the software poses risks that exceeds benefits
Zeitfenster: From patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)
|
Each time the software is used, clinicians are surveyed whether ongoing use of the software poses risks that exceeds benefits |
From patient arrival in the Emergency Department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Andrew Reisner, MD, Massachusetts General Hospital
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2022P001136
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .